Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 6 | |
Outperform | 7 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 11 analysts offering 12 month price targets for Genscript Biotech Corp have a median target of 26.03, with a high estimate of 30.00 and a low estimate of 15.98. The median estimate represents a 118.00% increase from the last price of 11.94.
High | 151.3% | 30.00 |
Med | 118.0% | 26.03 |
Low | 33.8% | 15.98 |
Earnings history & estimates in USD
Average growth rate | -39.36% |
More ▼
Revenue history & estimates in USD
Average growth rate | +32.59% |
More ▼